Pan Am
PARK STREET IMPORTS LLC — MIAMI, FL
England
About Pan Am
Pan Am is a vodka brand originating from England and registered with the TTB as an 80-89 proof spirit. According to TTB records, the brand maintains a single distinct product offering currently tracked in the vodka market. The brand received its first TTB label approval in 2024, representing its initial entry into the formal spirits registry system. Pan Am vodka is classified under standard vodka category specifications and falls within the mid-range proof category typical of many vodka products on the market. As an English-origin spirit, the brand represents offerings from the United Kingdom's spirits production landscape. The brand's presence in the TTB COLA database indicates it has completed the necessary regulatory approval processes required for commercial distribution in the United States. With one total label approval on record, Pan Am maintains a focused product portfolio within the vodka category.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Pan Am VODKA 80-89 PROOF FB | Vodka 80-89 Proof Fb | Approved | 2024-04-10 | PARK STREET IMPORTS LLC |
Page 1 of 1
Pan Am at a Glance
Pan Am has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof Fb. Labels approved between 2024-04-10 and 2024-04-10. Produced in England.
All information sourced from public TTB records.
Are you the owner or distributor of Pan Am?
Claim this brand listing to update information or get featured. Contact team@buy.vodka.
Produced At
Park Street Imports LLCRelated Brands
- Blacklion also from England
- Broken Clock Vodka also from England
- Cambridge Distillery also from England
- Desi Daru also from England
- III Big Dogs Vodka also from England
- Svedka also makes Vodka 80-89 Proof Fb
- Stoli also makes Vodka 80-89 Proof Fb
- Stolichnaya also makes Vodka 80-89 Proof Fb
- Van Gogh also makes Vodka 80-89 Proof Fb
- Beluga also makes Vodka 80-89 Proof Fb
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.